Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesStudy finds stroke risk from anemia drug Aranesp
USA Today, 11/02/09
A new study raises fresh safety concerns about widely used anemia medicines, finding that the drug Aranesp nearly doubled the risk of stroke in people with diabetes and chronic kidney problems who are not yet sick enough to need dialysis. The study is the largest ever of these blood–boosting drugs and the only one that compared them to a dummy treatment. The medicines have become blockbuster sellers because they lessen the need for transfusions, but their ability to prevent heart attacks, kidney failure or other problems have not been proven.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
New technology could boost disease detection tests speed and sensitivity
ScienceDaily, 12/09/09
Coffee Consumption Associated With Reduced Risk of Advanced Prostate Cancer
ScienceDaily, 12/09/09
Exercise can benefit men with prostate cancer
Reuters, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor